Vir Biotechnology, Inc. (VIR)
NASDAQ:VIR
Want to see VIR full AI Analyst Report?
Vir Biotechnology (VIR) Ownership Overview
10.09% Insiders
11.21% Mutual Funds
31.88% Other Institutional Investors
19.75% ETFs
27.07% Public Companies and
Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 62.84% of the company’s stock is owned by Institutional Investors, 10.09% is owned by Insiders, and 27.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 18, 2025 | xxxxxxxxxxxxx | $37734 | |
Nov 04, 2025 | xxxxxxxxxxxxx | $7999 | |
Jul 17, 2025 | xxxxxxxxxxxxx | $37106 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $4729088 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $197120 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $368435 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,728,924 | Insider | 8.14% | 120,402,663 | |
| 12,805,732 | Institution | 7.59% | 112,306,270 | |
| 11,321,378 | Institution | 6.71% | 99,288,485 | |
| 8,460,919 | Institution | 5.02% | 74,202,260 | |
| 5,214,824 | Institution | 3.09% | 45,734,006 | |
| 1,618,903 | Institution | 0.96% | 14,197,779 | |
| 1,160,346 | Institution | 0.69% | 10,176,234 | |
| 1,148,188 | Institution | 0.68% | 10,069,609 | |
| 1,078,391 | Insider | 0.64% | 9,457,489 | |
| 1,001,263 | Insider | 0.59% | 8,781,077 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,460,919 | Institution | 5.02% | 74,202,260 | |
| 1,618,903 | Institution | 0.96% | 14,197,779 | |
| 1,160,346 | Institution | 0.69% | 10,176,234 | |
| 1,148,188 | Institution | 0.68% | 10,069,609 | |
| 981,392 | Institution | 0.58% | 8,606,808 | |
| 807,718 | Institution | 0.48% | 7,083,687 | |
| 514,671 | Institution | 0.31% | 4,513,665 | |
| 447,935 | Institution | 0.27% | 3,928,390 | |
| 440,000 | Institution | 0.26% | 3,858,800 | |
| 409,998 | Institution | 0.24% | 3,595,682 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,892,399 | Institution | 4.09% | 64,788,551 | |
| 3,975,748 | Institution | 2.36% | 35,622,702 | |
| 2,902,839 | Institution | 1.72% | 26,009,437 | |
| 2,797,373 | Institution | 1.66% | 25,987,595 | |
| 2,188,157 | Institution | 1.30% | 20,568,676 | |
| 1,623,915 | Institution | 0.96% | 14,550,278 | |
| 1,266,373 | Institution | 0.75% | 11,346,702 | |
| 1,032,529 | Institution | 0.61% | 9,075,930 | |
| 808,581 | Institution | 0.48% | 7,600,661 | |
| 795,069 | Institution | 0.47% | 7,473,649 |
FAQ
Who Owns Vir Biotechnology, Inc. (VIR)?
According to the latest TipRanks data, approximately 31.88% of the company's stock is held by institutional investors, 10.09% is held by insiders, and 27.07% is held by retail investors.
What percentage of Vir Biotechnology, Inc. (VIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.88% of Vir Biotechnology, Inc. (VIR) stock is held by institutional investors.
What percentage of Vir Biotechnology, Inc. (VIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.07% of Vir Biotechnology, Inc. (VIR) stock is held by retail investors.
Who owns the most shares of Vir Biotechnology, Inc. (VIR)?
SVF Endurance (Cayman) Ltd owns the most shares of Vir Biotechnology, Inc. (VIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.